Showing results (201-210 of 250) with videos related to
Sort By:
Pageof 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium StudyTimothy F Cloughesy, Patrick Y Wen, H Ian Robins, et al.Journal of Neuro-Oncology|October 13, 2006
A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiformeMorris D Groves, Vinay K Puduvalli, Susan M Chang, et al.Neuro-Oncology Advances|November 25, 2020
Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02Huanwen Chen, John Kuhn, Kathleen R Lamborn, et al.Neuro-Oncology|September 22, 2016
Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trialsEdward K Avila, Marc Chamberlain, David Schiff, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2005
Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphomaLauren E Abrey, Tracy T Batchelor, Andrés J M Ferreri, et al.Neuro-Oncology|February 13, 2010
A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapyJeffrey J Raizer, Lauren E Abrey, Andrew B Lassman, et al.Neuro-Oncology|June 28, 2020
Clinical trial of proton craniospinal irradiation for leptomeningeal metastasesT Jonathan Yang, Neil A Wijetunga, Josh Yamada, et al.Neurology|August 10, 2022
Combination Olaparib and Temozolomide for the Treatment of Glioma: A Retrospective Case SeriesLauren R Schaff, Marina Kushnirsky, Andrew L Lin, et al.Neuro-Oncology|March 22, 2008
Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomasKathleen R Lamborn, W K Alfred Yung, Susan M Chang, et al.Neuro-Oncology|August 22, 2025
Multicenter basket trial for Central Nervous System tumors identifies activity of the CDK4/6 inhibitor abemaciclib in recurrent meningiomaThomas J Kaley, Christian Grommes, Elizabeth Coffee, et al.Pageof 25